Dubai PR Network, Online Press Release from Dubai and Middle East
 
Health & Fitness(Healthcare & Medicine)
Filter PR by
  
FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product
 

Dubai, United Arab Emirates, July 08, 2020:  The U.S. Food and Drug Administration (FDA) today authorized the marketing of IQOS, Philip Morris International’s (PMI) electrically heated tobacco system, as a modified risk tobacco product (MRTP). In doing so, the agency found that an IQOS exposure modification order is appropriate to promote the public health.

- Today’s decision demonstrates that IQOS is a fundamentally different tobacco product and a better choice for adults who would otherwise continue smoking
- IQOS is the first and only electronic nicotine product to be granted marketing orders through the FDA’s MRTP process
- The FDA authorized the marketing of IQOS with the following information:
- The IQOS System heats tobacco but does not burn it
- This significantly reduces the production of harmful and potentially harmful chemicals
- Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system reduces your body’s exposure to harmful or potentially harmful chemicals.
- The agency concluded that the available scientific evidence demonstrates that IQOS is expected to benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products
- The FDA’s decision further builds on the emerging independent international scientific consensus that IQOS is a better choice than continuing to smoke, and follows the FDA’s April 2019 decision authorizing the commercialization of IQOS in the U.S.
- The FDA’s decision provides an important example of how governments and public health organizations can regulate smoke-free alternatives to differentiate them from cigarettes in order to protect and promote the public health

 


This decision follows a review of the extensive scientific evidence package PMI submitted to the FDA in December 2016 to support its MRTP applications.
Commenting on the FDA’s announcement, André Calantzopoulos, PMI’s Chief Executive Officer, said:
“The FDA’s decision is a historic public health milestone. Many of the tens of millions of American men and women who smoke today will quit—but many won’t. Today’s decision makes it possible to inform these adults that switching completely to IQOS is a better choice than continuing to smoke. FDA determined that scientific studies show that switching completely from conventional cigarettes to IQOS reduces exposure to harmful or potentially harmful chemicals.
IQOS is a fundamentally different product than combustible cigarettes and must be regulated differently, as the FDA has recognized. Now—more than ever—there is an urgent need for a fundamentally different conversation on a cooperative approach to achieve a smoke-free future. The FDA’s decision provides an important example of how governments and public health organizations can regulate smoke-free alternatives to differentiate them from cigarettes in order to promote the public health.


We are excited that this important decision will help guide the choices of adult smokers in the U.S. The best choice for health is to never start smoking or to quit altogether. For those who don’t quit, the best thing they can do is switch to a scientifically substantiated smoke-free product. As of March 31, 2020, PMI estimates that approximately 10.6 million adult smokers around the world have already stopped smoking and switched to IQOS. We believe that this decision can help to further accelerate the transition of U.S. adults away from cigarettes. We, along with our licensee Altria, are committed to guarding against unintended use and fully support FDA’s focus on protecting youth.


Today’s decision is a result of our ongoing commitment to put science at the forefront as we continue on our quest to replace cigarettes with smoke-free alternatives as quickly as possible.


We look forward to working with the FDA to provide any additional information they may require in order to market IQOS with reduced risk claims.
Harnessing innovations like IQOS to dramatically speed-up the decline in cigarette smoking is the opportunity of this century. Comprehensive, science-based regulation can help to rapidly shift adult smokers who would otherwise continue smoking to better options, while simultaneously guarding against unintended consequences.”


Posted by : Dubai PR Network Editorial Team
Viewed 8192 times
PR Category : Healthcare & Medicine
Posted on : Wednesday, July 8, 2020  12:52:00 PM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Traveler Survey Reveals COVID-19 Concerns
Next Story : Honeywell Announces Solutions to Help Improve Building Healt...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Herbal Essences Taps into Nature's most Powerful Ingredients with the new Potent Aloe Vera... [10750-Views]
Hello 2021, HELLO, GOOD STUFF! with Essence [7892-Views]
Middle East Hotels Ready to Capitalise on Workation Trend, says ATM [7487-Views]
IRENA's World Energy Transition Day Kick-Starts Crucial Assembly Meeting [6892-Views]
Latest PGA Tour Winner Kevin Na Joins Strong American Contingent vying for 2021 Saudi Inte... [5523-Views]
How Small Travel & Tourism Business can Overcome COVID-19 Pandemic [5367-Views]
Join the A-Beauty Revolution with Sukin's Buy 2 Get 2 Limited Time Offer [4079-Views]
Danube Group Launches World's First Civil Defence Approved Alucopanel A1 Aluminium Composi... [3768-Views]
Pampers Introduces the First Diaper Designed for Nighttime Wetness Protection and Un-inter... [3592-Views]
Jaguar Land Rover Mena Offers Customers Warranty Extension Lasting Up to 10 Years [3542-Views]
A New Wave of Coffee has Arrived at AlBarari [3378-Views]
Sony Middle East & Africa Launches Newest Addition to G Master™ Full-Frame Lens Series wit... [3292-Views]
Henrik Stenson Leads Past Winners' Delight for Omega Dubai Desert Classic Return [3149-Views]
Icon Racing Sport Collection [3128-Views]
Etihad Airways to Recommence Flights to Doha [3116-Views]
Dubai Sports Council Launch Dubai's First All-Schools Sports Tournament Series [2948-Views]
Abu Dhabi Delivers Knockout Opportunity for UFC Fight Island Triple Header Spectators to A... [2940-Views]
Statements of Love [2927-Views]
Take Special Care of your Skin with Martiderm [2886-Views]
Ericsson: Smart Home Privacy: How to avoid ‘Data Paparazzi' [2800-Views]
Jalabiyas – Epitome of Grandeur, Grace and Elegance [2567-Views]
Two Proven Solutions to Instantly Revive Your Skin [2542-Views]
Samsung Introduces a One-Stop Shop that Curates Every Step of Your Cooking Journey [2398-Views]
Red, Blush and Black - Steve Madden Is Ready to Celebrate Valentine's Day With the Quintes... [2321-Views]
Tondagraph GT Rose Gold Blue [2222-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories